CD79A and neoplasm: Thus, tumor cells often express pan B-cell markers (cluster of differentiation 19 [CD19], CD29, CD79a) and in 90% of cases express BCL-6 and MUM1, whereas plasma cell-associated proteins such as CD38 and CD138 are usually absent [17].